Wednesday 6-25-2014 Ariad Pharmaceuticals (ARIA) $ARIA

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Wednesday 6-25-2014 Ariad Pharmaceuticals (ARIA) $ARIA opened at 6.31 hitting the high price of 6.43 and a day low of 6.26 with a total volume of 5,275,644. ARIA had a previous close of 6.31 and has been seeing an average volume of 7,969,280.

Overall Average: 72% Sell

Recent stock forum discussions about ARIA http://investorshangout.com/search?q=ARIA&...mp;yt0=Go!

Ariad Pharmaceuticals Up 72.2% Since SmarTrend Uptrend Call (ARIA)
Comtex SmarTrend(R) - Wed Jun 25, 9:08AM CDT
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on November 22nd, 2013 at $3.67. In approximately 7 months, Ariad Pharmaceuticals has returned 72.21% as of today's recent price of $6.32. (full story)

Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 4:20PM CDT
Merck KGaA (MKGAF) inked a deal with Mersana Therapeutics for the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. (full story)

Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 8:18AM CDT
Ohr Pharmaceutical, Inc. (OHRP) was a big mover last session, as the company saw its shares rise by almost 17% on the day. (full story)

Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 7:35AM CDT
Alcobra stock fell nearly 7% last trading session, reversing its recent uptrend (full story)

Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:46AM CDT
Cardiome Pharma (CRME) was a big mover last session, with shares rising over 7% on the day. (full story)

Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:39AM CDT
Genocea Biosciences, Inc. (GNCA) was a big mover last session, as its shares rose nearly 9% on the day. (full story)

Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:25AM CDT
Heron Therapeutics (HRTX) was a big mover last session, with shares rising over 7% on the day. (full story)

Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:57AM CDT
Cerulean Pharma has seen negative earnings estimate revision for the current quarter along with a significant decline in its share price for the last day (full story)

Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:51AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as its shares rose nearly 19% on the day. (full story)

ARIAD Announces Three Key Appointments to Its Global Management Team
Business Wire - Mon Jun 23, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety and pharmacovigilance. (full story)

FDA Drops the Hammer on Twitter
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Jun 22, 4:30PM CDT
The FDA just announced new regulations for pharma and biotech companies that wish to promote their drugs via  Twitter  (Nasdaq: TWTR). Companies cannot brag about a drugs benefits without also tweeting about the associated risks of taking it. There... (full story)

Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 4:20PM CDT
Tetraphase Pharmaceuticals (TTPH) announced the completion of patient enrolment for the phase III IGNITE 2 study on eravacycline. (full story)

Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 8:18AM CDT
Aerie Pharmaceuticals, Inc. (AERI) was a big mover last session, as the company saw its shares rise by almost 7% on the day. (full story)

BioLineRx to Commence BL-8040 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:10PM CDT
BioLineRx Ltd. (BLRX) announced that the Israeli Ministry of Health informed the company that it can start a phase I study on its oncology candidate, BL-8040. (full story)

Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:56AM CDT
Endocyte, Inc. (ECYT) saw a big move last session,reversing the most recent trend for ECYT as the stock is now up around 7.6% since June 3, 2014 (full story)

Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:51AM CDT
Receptos, Inc. (RCPT) was a big mover last session, as its shares rose nearly 7% on the day. (full story)

Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session - Tale of the Tape
Abhijit Ghosh - Zacks Investment Research - Thu Jun 19, 7:30AM CDT
Flexion Therapeutics, Inc. (FLXN) was a big mover last session, as its shares rose nearly 16% on the day. (full story)

Merck KGaA-Ono Pharma Deal Ends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 5:15PM CDT
Merck KGaA (MKGAF) has decided to terminate its license agreement with Ono Pharma related to the development of Ono Pharma's multiple sclerosis candidate, ceralifimod (ONO-4641). (full story)

Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 11:10AM CDT
Endocyte, Inc. (ECYT) announced that it has regained worldwide rights to oncology candidate, vintafolide, as Merck decided to discontinue its investment in the development of vintafolide. (full story)

Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 7:44AM CDT
Portola Pharmaceuticals, Inc. (PTLA) was a big mover last session, as the company saw its shares gain nearly 6% on the day. (full story)

ARIAD Pharmaceuticals Inc. (ARIA) Stock Research Links

ARIA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Luxury Air Celebrates 18 Years of Comfort Service

Updated Category News Views 2

Celebrating 18 Years: A Journey of Comfort It's not often you see a business weave itself so seamlessly into the fabric of its community. But that's exactly what Luxury Air A/C & Heating has done in Conroe, The Woodlands, and across Montgomery County. Hit 18 years in the HVAC game, and you've clearly nailed something other folks can't quite replicate. Guess there's no...

Continue Reading
TriStar Bank Community Room: A Space for Growth

Updated Category News Views 1

Building Bridges Through Community Investment Well, ain't this something? Columbia, Tennessee, just got a splash of fresh air. We're talking about the new Southern Regional Technology Center nested in Columbia State Community College. Now, the name on everyone's lips? The TriStar Bank Community Room. But it ain't just about a name plastered up on a wall inside a shiny...

Continue Reading
BMO Sheds U.S. Branches, Eyes Strategic Growth

Updated Category News Views 1

Why BMO is Slimming Down in the States You know, when a heavyweight like BMO Financial Group starts shedding branches left and right, you gotta ask yourself what the grand plan is. In a move that looks more like a strategic dance than an abrupt U-turn, BMO's gotten rid of 138 U.S. branches, handing them over to First-Citizens Bank. We're talking outlets scattered from...

Continue Reading
Primero Gains Global Edge with Win Systems Buy

Updated Category News Views 2

Here's the move: Primero Games, the U.S.-based gaming maestro, just grabbed a hefty piece of the puzzle with their acquisition of Win Systems' Gaming Division. Not two companies merging into obscurity, but a strategic maneuver aiming to scatter new seeds in Latin America and the Caribbean with over 3,000 gaming positions primed and ready. What's in the Pot? You've got...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 0

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading
EF English Live's Approach to Workplace Confidence

Updated Category News Views 3

Pioneering English Confidence for the Global Workplace Stepping into a meeting with international partners requires more than just textbook knowledge of English. It's about confidently expressing ideas, adapting on the fly, and engaging with global colleagues. Enter EF English Live, a leader in transforming workplace communication through targeted English learning. Expert...

Continue Reading
PerfectVape Unveils Online Deals Amid Vape Craze

Updated Category News Views 3

PerfectVape's Digital Bargain Bonanza Alright, so you think you've seen savings? Well, PerfectVape's throwing a real bone to those hunting for vape deals online. They're slapping 10% off on select disposable vapes—no strings, just a promo code, PV10, you punch in at checkout. We've got ourselves an internet-era sale without needing to elbow through crowds. Browsing Made...

Continue Reading
Raiders' Telenovela Hype Ignites Passion in Mexico

Updated Category News Views 1

Raider Nation's Heart Beats in Mexico Hell, you ever see a football game that feels like a soap opera? You bet your boots that's exactly what the Raiders are cooking down in Mexico City. We're not talking about just any ol' season opener; it's the curtain call of Corazón de Plata y Negro. This ain't your average fanfare—it's a spectacle teeming with raw, unfiltered...

Continue Reading
Tech Job Market Surges: 86,000 Hires in August Boost

Updated Category News Views 2

Tech Job Growth Defies Corporate Layoffs Job markets in the tech world are hotter than a two-dollar pistol. Despite seeing some layoffs in tech firms, the demand for skilled tech workers is still booming. You got tech companies tightening the bolts, laying off around 14,700 folks, but here's the kicker: overall tech employment shot up with 86,000 new jobs in August....

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading

Top 5 Most Recently Viewed Articles

Ohana Real Estate Investors: Honored as Top Hotel Group in 2026

Updated Category News Views 300

A Stellar Achievement in Hospitality Just when you think the hotel industry can't get any more competitive, Ohana Real Estate Investors goes and bags the "Hotel Ownership Group of the Year" from the Forbes Travel Guide at their Summit in Monaco. This isn’t just a trophy on a mantle; it's a serious nod from the big players at CBRE and FTG, recognizing years of solid...

Continue Reading
Ionis Pharmaceuticals Sells $500 Million in Stock Offering

Updated Category News Views 126

Ionis Pharmaceuticals Unveils Major Stock Offering Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has announced a significant financial move involving a public offering of common stock. This underwritten offering includes 11,500,000 shares, each priced at $43.50, with total gross proceeds projected to reach an impressive $500.3 million. The funds raised are intended to...

Continue Reading
BPCE SFH's Strategic Restructuring for Noteholders Ahead

Updated Category News Views 105

Notice to Noteholders from BPCE SFH Notice to Noteholders To: Noteholders From: BPCE SFH 7, promenade Germaine Sablon 75013 Paris Copy: Fiscal Agent, Principal Paying Agent, and Calculation Agent: BNP Paribas Securities Services Les Grands Moulins de Pantin 9 rue du Débarcadère 93500 PANTIN BPCE SFH (“Issuer”) Legal Entity Identifier (LEI): 969500T1UBNNTYVWOS04...

Continue Reading
IMUNON Highlights Progress in Ovarian Cancer Treatment Plans

Updated Category News Views 109

Company Overview IMUNON, Inc. (Nasdaq: IMNN) is a clinical-stage biotechnology company dedicated to advancing innovative cancer therapies that leverage the body's natural defenses. The company focuses on developing a range of pioneering treatments utilizing their non-viral DNA technology platform. Recent Financial Results In its second quarter of 2025, IMUNON reported a...

Continue Reading
Supernus Pharmaceuticals Announces Q3 Earnings Call Details

Updated Category News Views 34

Supernus Pharmaceuticals Plans Third Quarter Earnings Call Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a leading biopharmaceutical company, is excited to share details about their upcoming conference call to discuss financial results for the third quarter of 2024. This event is set to take place shortly after the market closes, scheduled for November 4, 2024. Overview...

Continue Reading